~~<i id='F25D3FFE36'><strike id='F25D3FFE36'><tt id='F25D3FFE36'><pre id='F25D3FFE36'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

focus

hotspot

author：hotspot 2025-10-06 19:10:06 - browse：2831

Adam's take main illustration — Molly Ferguson/STAT

I was wrong about Geron.

For years, I’ve believed — and declared publicly — that Geron’s effort to develop a blood cancer drug called imetelstat would end in disappointment. The drug was never getting approved, I said.

On Thursday, a group of outside experts convened by the Food and Drug Administration voted 12-2 in imetelstat’s favor, concluding the drug’s benefits outweighed its risks for the treatment of patients with myelodysplastic syndrome. The strong endorsement makes an FDA approval highly likely. The decision is expected on or before June 16.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Sports medicine is finally prioritizing gender equality
Next article： The Affordable Care Act has saved billions in health care costs

hotspot

knowledge

leisure time

focus

entertainment

Wikipedia

Thefinancechiefofthecountry’slargestprivatepsychiatrichospitaloperator,UHS,madeabluntstatementtoday:

WSS

Vertex non

New Alzheimer's drugs heat up race for early detection blood tests

The battle over 'scope creep' and who gets to be called 'doctor'

How generative AI ratchets up security threats for health systems

Readout Newsletter: CG Oncology IPO, Eli Lilly, Tesla, Merck

Biden warns of ‘dark winter’ during final presidental debate

focus

hotspot

hotspot

In age of alternative facts, a scholarly course on calling out crap

Device maker Teleflex to acquire urology company for $600M

How one medical school became remarkably diverse

Readout Newsletter: Vertex, Pfizer, Kura, and other biotech news

State Dept. review finds Biden bears some blame for Afghanistan failures

New clues to why women have higher risk of autoimmune disorders

Anesthesiologist group: stop taking Ozempic before surgery

Investment in vaccine development is lagging, report finds

Virginia high school admissions case could be legal follow

What it's like to live with paralysis for one psychologist

knowledge

In the gardens at Boston Children's Hospital, families find sanctuary

Zyn nicotine pouches become unlikely player in latest culture war

What causes rare myocarditis in young men after Covid vaccines?

Why Medicare shouldn’t cover every FDA

STAT Report: Patient voices and perspectives

What to watch for from Zogenix and Amicus clinical trials

leisure time

focus

entertainment

Wikipedia